Patrice Wendling

Cardiac biomarkers vary according to sex hormones in healthy transgender adults, just as in cisgender individuals, a new cross-sectional study suggests.

Virtual platforms democratized scientific meetings during the COVID-19 pandemic but, as any meeting-goer will tell you, it's the questions from the floor and the back-and-forth of an expert panel that often reveal the importance of and/or problems with a presentation. It's the scrutiny that makes the science resonate, especially in this postfactual era.

Wearable devices once seemed futuristic for Parkinson’s disease. Today, tools like activity trackers, tremor gloves, and laser canes are transforming the management of the disease.

Less than a decade ago, the use of wearable devices in Parkinson's disease (PD) was considered futuristic.

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

Dapagliflozin might reduce the risk for ventricular arrhythmias and sudden death in patients with heart failure and reduced ejection fraction (HFrEF), a post hoc analysis of the DAPA-HF trial suggests.

A drug that combines an atypical antipsychotic and an SSRI is under FDA review, and if approved will be the first FDA-approved medication for PTSD in more than 20 years.

January 1, 2010 | Dermatology Author and Disclosure Information

March 1, 2008 | Dermatology Author and Disclosure Information

Being obese and pregnant raises the risk for cardiac complications in women with preexisting heart disease, new research suggests, highlighting the need for earlier interventions in this high-risk population.